Churchill Capital II Stock Forecast [Time To Buy SPACs?]

Market News Know Your Risk Before You Trade --------------------------------------------------------------- Free "dummies guide" to trading options Did you know trading options can actually be safer and more profitable than buying and selling stocks? Best-selling author reveals his simple safe way to start trading options in this FREE GUIDE. It's 100% free until the end of the month. [Access now.](~/AACAmgA~/RgRfynBMP0Q0aHR0cDovL3d3dy5vcHRpb25zcHJvZml0YWNjZWxlcmF0b3IuY29tLzE2Njc1Mzctc28tMVcDc3BjQgoAJWXr5131HOZgUht0cmlzdHJhbWJhbGR3aW44OUBnbWFpbC5jb21YBAAAAAE~) Sponsored --------------------------------------------------------------- Churchill Capital II Stock Forecast [Time To Buy SPACs?] Churchill Capital II Stock Forecast: Buying stock in a company with a well-known brand is pretty straightforward. You already know the industry you are putting your money into, and a bit of research gives you an in-depth understanding of the organization’s financials. Your investment is a vote of confidence in the company’s future profitability, and […] [Click Here to Continue Reading](~/AACAmgA~/RgRfynBMP0RJaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9jaHVyY2hpbGwtY2FwaXRhbC1paS1zdG9jay1mb3JlY2FzdFcDc3BjQgoAJWXr5131HOZgUht0cmlzdHJhbWJhbGR3aW44OUBnbWFpbC5jb21YBAAAAAE~) --------------------------------------------------------------- Check out the Seasonal Trend for SLG [View Seasonality for SLG](~/AACAmgA~/RgRfynBMP0R1aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9zZWFyY2gvc2Vhc29uYWxpdHkvU0xHP3V0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1CbG9nRGlnZXN0JnV0bV9jYW1wYWlnbj0yMDE5MTIwNF9uZXdzbGV0dGVyVwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) --------------------------------------------------------------- [Bizarre Cannabis "Hack" Could Make You A Marijuana Millionaire](~/AACAmgA~/RgRfynBMP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTUzMiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGc0TnlaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNVGc9VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) Elite researchers have quietly developed a cannabis "hack" that could revolutionize the $150 billion industry... and make investors incredibly rich. We're looking at an opportunity that's bigger than the tech boom of the 90's. Bigger than the oil spike of 2008. Even bigger than the bitcoin craze of 2017! [Click here to find out how this "moonshot" could hand you 997% profits in the next 12 months.](~/AACAmgA~/RgRfynBMP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTUzMiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGc0TnlaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNVGc9VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored --------------------------------------------------------------- Best Stock Market Movies of All Time Best Stock Market Movies Of All Time: The world of finance is high drama. In a single day, the stock market can make you laugh, cry, and celebrate in a way that little else can. Hollywood tries to get on that scene, but they don’t always get it right. To film a movie about the […] [Click Here to Continue Reading](~/AACAmgA~/RgRfynBMP0RKaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9iZXN0LXN0b2NrLW1hcmtldC1tb3ZpZXMtb2YtYWxsLXRpbWVXA3NwY0IKACVl6-dd9RzmYFIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAB) --------------------------------------------------------------- Fulgent Genetics Stock Forecast [7,600 Genetic Conditions Tested] Fulgent Genetics Stock Forecast: Investing in genetics stocks and genome processing may sound like the next frontier, but this industry could be the next big thing. This science technology is the basis for a new type of medicine called “precision healthcare.” It lets doctors customize prescribed treatments based on the individual genetics of each patient. […] [Click Here to Continue Reading](~/AACAmgA~/RgRfynBMP0RFaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9mdWxnZW50LWdlbmV0aWNzLXN0b2NrLWZvcmVjYXN0VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) --------------------------------------------------------------- Catalyst Pharmaceuticals Stock Forecast [Failed Clinical Trials Spells Gloom] Catalyst Pharmaceuticals Stock Forecast: Some diseases so uncommon that they affect fewer than 200,000 patients. Such conditions fall under the United States’ classification of rare or orphan diseases, because they are so unusual. These conditions are more challenging to diagnose, simply due to physicians’ lack of experience with them, and treatment options are limited. Worse still, […] [Click Here to Continue Reading](~/AACAmgA~/RgRfynBMP0RNaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9jYXRhbHlzdC1waGFybWFjZXV0aWNhbHMtc3RvY2stZm9yZWNhc3RXA3NwY0IKACVl6-dd9RzmYFIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAB) --------------------------------------------------------------- 7 Top Santa Claus Rally Stocks To Buy Best Santa Claus Rally Stock To Buy: Every year in the build up to the holidays you’ll hear the CNBCs and Bloombergs of the world talk about the Santa Claus rally – a phenomenon where stocks rally during the final weeks of December and into the New Year. But which ones deserve your attention? We […] [Click Here to Continue Reading](~/AACAmgA~/RgRfynBMP0RJaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy90b3Atc2FudGEtY2xhdXMtcmFsbHktc3RvY2tzLXRvLWJ1eVcDc3BjQgoAJWXr5131HOZgUht0cmlzdHJhbWJhbGR3aW44OUBnbWFpbC5jb21YBAAAAAE~) --------------------------------------------------------------- [Has Trump Turned This $5 Stock Into The Biggest Opportunity Of All Time?](~/AACAmgA~/RgRfynBMP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTUzNiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGc0TlNaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNVGM9VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you. [Click here for more](~/AACAmgA~/RgRfynBMP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTUzNiZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGc0TlNaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNVGM9VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored --------------------------------------------------------------- [Stock Market algorithm makes shockingly accurate predictions](~/AACAmgA~/RgRfynBMP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTUyNyZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGczT0NaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNVEU9VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) A software expert has created an algorithm that detects stock market trends with shocking accuracy. It's creator, Tom Gentile, is giving common people who are invested (or interested in investing) in the stock market, a rare chance to access the recommendations he finds using this system. A system which allows you to circle a date on a calendar, and know, with at least 90% certainty, that you could cash in on that day. [Learn all the details here.](~/AACAmgA~/RgRfynBMP0ScaHR0cDovL2ZpbmFuY2hpbGwuY29tL2FkP3R5cGU9aW1zJmlkPTUyNyZhZD1hSFIwY0hNNkx5OXBiWE53ZFdKc2FYTm9aWEpuY205MWNDNW5iekpqYkc5MVpDNXZjbWN2WVdabVgyTS9iMlptWlhKZmFXUTlORGczT0NaaFptWmZhV1E5TVRFMU5DWm1hV3hsWDJsa1BUSXhNVEU9VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~) Sponsored --------------------------------------------------------------- View this email [online](~/AACAmgA~/RgRfynBMP0QaaHR0cDovL2ZpbmFuY2hpbGwuY29tL2Jsb2dXA3NwY0IKACVl6-dd9RzmYFIbdHJpc3RyYW1iYWxkd2luODlAZ21haWwuY29tWAQAAAAB) if it doesn't display correctly. This newsletter is not financial advice. Please read our [Disclaimer](~/AACAmgA~/RgRfynBMP0QbaHR0cDovL2ZpbmFuY2hpbGwuY29tL3Rlcm1zVwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~). --------------------------------------------------------------- Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory. The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email. The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: [Characteristics and Risks of Standardized Options](~/AACAmgA~/RgRfynBMP0RFaHR0cDovL3d3dy5vcHRpb25zY2xlYXJpbmcuY29tL2Fib3V0L3B1YmxpY2F0aW9ucy9jaGFyYWN0ZXItcmlza3MuanNwVwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~). The Financhill.com educational training program and software services are provided to improve financial understanding. The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing. Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated. To unsubscribe from the Market News Newsletter, [click here](~/AACAmgA~/RgRfynBMP0RXaHR0cDovL2ZpbmFuY2hpbGwuY29tL0dyZWF0T2ZmZXJzRm9yWW91LzhjNmU2NmRmNDRjNWQ4NzY0OGEzMmI4NzhjOTAyZjE2LTE1MDczMTE1LTg2OTE0VwNzcGNCCgAlZevnXfUc5mBSG3RyaXN0cmFtYmFsZHdpbjg5QGdtYWlsLmNvbVgEAAAAAQ~~).